This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
In a small randomized, controlled trial of patients with FFA with an open-label extension at 12 weeks, symptoms of moderate to severe frontal fibrosing alopecia improved with topical delgocitinib.
Medscape Medical News